Peptidyl Arginine Deiminase, Type III (PADI3) Antikörper

Antigen: Peptidyl Arginine Deiminase, Type III (PADI3)

Synonyme: PAD3, PDI3, MGC126307, MGC126308, Pad3, Pdi3, AI507004, KIAA4171, mKIAA4171, PADI3

Klonalität: Polyklonal

Wirt: Kaninchen

Reaktivität: Human, Ratte (Rattus), Maus

Applikation: ELISA, Immunhistochemie (IHC), Immunpräzipitation (IP), Western Blot (WB)

Produktnummer: ABIN347067

Produktbeschreibung

Weitere Bezeichnung: Peptidylarginine deiminase type III (PAD-3)

Immunogen: A15 residue synthetic peptide derived from N-terminal domain

Format: Antiserum

Spezifität: Antiserum reacts specifically with 75 kDa of PAD3 protein from mouse, human and rat. Cross Reactivities: There is no cross reaction with the other isoforms

Anwendungen

Applikationshinweise: Optimal dilutions should be determined by the end user.The following are guidelines only: ELISA :1/5 000 to 1/20 000. Immunohistochemistry : 1/50 to 1/500. Immunoprecipitation : 1/20 to 1/100. Western Blot : 1/200 to 1/2 000

Buffer: Lyophilized from 100 µl of serum. Preservative: None.

Lagerung: Short term storage: +4°C. Long term storage: -20°C

Beschränkungen: Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen: Kanno, Kawada, Yamanouchi et al.: "Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin." in: The Journal of investigative dermatology, Vol. 115, Issue 5, pp. 813-23, 2000 (PubMed).

Muechin, Enji, Nachat et al.: "The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations." in: Cellular and molecular life sciences : CMLS, Vol. 62, Issue 17, pp. 1984-95, 2005 (PubMed).